There may be an existing solution to the chronic disease crisis, but a disabled patient seems to be the only person motivated enough to try to obtain it. And they've been failing going at it alone.

MaximilianKohler@lemmy.world · 6 months ago

There may be an existing solution to the chronic disease crisis, but a disabled patient seems to be the only person motivated enough to try to obtain it. And they've been failing going at it alone.

mommykink@lemmy.world · edit-2 6 months ago

Reminder that the FDA is the state mechanism to protect the wealth of the pharmaceutical giants. The very few times they (the FDA) actually facilitate improvements in medicine/health are only as a side effect of that mission and are completely incidental.

MaximilianKohler@lemmy.world · 6 months ago

Dr. Alexander Khoruts (University of Minnesota GI, Director, UMN Microbiota Therapeutics Program) made a similar comment. https://forum.humanmicrobiome.info/threads/designer-hit-panel-discussion-achieving-cures-together-dec-2023-peter.216/

He asks an FDA adviser “Does the FDA care more about profits or people?”, and the response he gets is “one of the missions of the FDA is to protect the interests of commercial developers”. Another question to the advisor: “How much influence does the industry have over the FDA decisions?”, A: “A lot”.

There may be an existing solution to the chronic disease crisis, but a disabled patient seems to be the only person motivated enough to try to obtain it. And they've been failing going at it alone.

There may be an existing solution to the chronic disease crisis, but a disabled patient seems to be the only person motivated enough to try to obtain it. And they've been failing going at it alone.

The FDA and FMT regulation. Part 1. — Human Microbes